Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection

The global pandemic of COVID-19 disease caused by infection with the SARS-CoV-2 coronavirus, has produced an urgent requirement and search for improved treatments while effective vaccines are developed. A strategy for improved drug therapy is to increase levels of endogenous reactive metabolites for...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Motawa, Maryam S., Abbas, Hafsa, Wijten, Patrick, de la Fuente, Alberto, Xue, Mingzhan, Rabbani, Naila, Thornalley, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581855/
https://www.ncbi.nlm.nih.gov/pubmed/33162891
http://dx.doi.org/10.3389/fphar.2020.585408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581855/
https://www.ncbi.nlm.nih.gov/pubmed/33162891
http://dx.doi.org/10.3389/fphar.2020.585408

Ejemplares similares